Eyenovia Announces FDA Approval of Coastline International as Contract Manufacturer to Initiate Mydcombi Commercial Production
02.11.2023 - Anticipates having product available to ship in January 2024NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) - Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic technology company commercializing Mydcombi for mydriasis, preparing for regulatory approval of ... Seite 1